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INTRODUCTION
Protein phosphorylation is the most prevalent post-translational modification (PTM) and the resulting activation/deactivation of proteins plays an essential regulatory role in a wide variety of biological processes. 1, 2 Western blotting, immunohistochemical staining, and enzyme-linked immunosorbent assay (ELISA) are indispensable tools for monitoring phosphorylation changes using phosphospecific antibodies. However, these approaches have been severely limited by the availability and quality of phospho-specific antibodies, constraining analyses only to well-characterized phosphorylation events. 3 While applications of mass spectrometry (MS) lead to the discovery of numerous novel phosphorylation events every day, an effective antibody has to be made for every single phosphorylation site on individual proteins for validation, making it the bottleneck step in many discovery efforts. 4, 5 Researchers working on model organisms, such as S. cerevisiae, Drosophila, and Arabidopsis Thaliana, do not have access to commercial phosphospecific antibodies and have to use undesirable methods such as 32 P radioactive labeling.
Reverse phase protein array (RPPA) is an emerging high throughput approach that provides protein expression data across a large set of biological samples simultaneously. [6] [7] [8] [9] In a general RPPA workflow, denatured protein samples from cells, body fluids, tissues, and so on are directly spotted on a membrane. Subsequently, the membrane array is incubated with an antibody specific for the antigen of interest and visualized to estimate the protein concentration. Multiplexing is achieved by probing multiple arrays spotted with the same lysate with different antibodies simultaneously or probing different lysate with the same antibodies. The throughput, sensitivity and requirement of one single antibody in contrast to antibody pairs in Sandwich assays, together with its ability to deal with minuscule sample amounts, have propelled applications of the technology in basic, preclinical, and clinical research fields. For example, as the RPPA works with tiny amounts of proteins, the implementation of RPPA into clinical practice could help evaluate protein-based biomarkers. 10 RPPA has also been used as a powerful tool for signaling pathway profiling. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   4 Despite the success, RPPA, which relies heavily on the paucity of high-quality monospecific antibodies, is highly limited for the detection of proteins with post-translational modifications (PTMs) such as phosphorylated proteins, due to the relatively low availability and low quality of phospho-specific antibodies. 12 Moreover, an overwhelming number of nonphosphoproteins usually present in the sample, and the high complexity with tens of thousands of proteins in cell lysates or tissue extracts makes it extremely challenging to detect phosphoproteins which are usually of low abundance. 13 
MATERIALS AND EXPERIMENTAL PROCEDURE
Materials. All chemicals for the synthesis of Ti(IV) functionalized soluble nanopolymer, Amicon Ultra centrifugal filter units, the purified cJun, and the primary antibodies were obtained from Sigma-Aldrich. The secondary antibodies linked with IRDye® 800 were purchased from LI-COR Biosciences. The sample printing pin was obtained from Arrayit. SnakeSkin® pleated dialysis tubing (3,500 MWCO, 22 mm dry diameter) and BCA Protein Assay Kit were purchased from Pierce. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Sample spotting and detection by RP3A. Prepared protein lysates were spotted on the membrane using a pipette tip or microarray printing pin (Arrayit® SMP15B).
After the membrane was dried, it was washed with 0.05% SDS in TBST for three were placed in a chamber at 4 °C, and the seedlings before and after cold treatment were collected. For ABA, mannitol, and flg22 treatment, the 10-day-old seedlings were transferred to 4 mL liquid MS media, and then ABA, mannitol, and flg22 were added to the media with the final concentration of 50 µM, 800 mM, and 100 nM. At indicated time point, the seedlings were collected for protein extraction. The total proteins were extracted by using the following extraction buffer: 100 mM Tris-HCl pH 7.5, 150 mM NaCl, 5% Glycerol, 1 mM DTT, 1mM PMSF, 10 µM antipain, 10 µM aprotinin, 10 µM leupeptin, and phosphatase inhibitor cocktail set II (Sigma-Aldrich). The concentration of total proteins was measured by using Quick Start Bradford Dye Reagent (Bio-Rad) and finally the concentration of each protein sample was adjusted to the same level. Samples then were diluted with 2% SDS and boiled for spotting.
Arabidopsis Thaliana sample preparation for phosphopeptides enrichment and LC-MS/MS analysis.
The sample preparation procedure is based on published paper 14 . Briefly, the extracted proteins were digested with Lys C for 3 hours and then digested with trypsin for another 12 hours to obtain peptides mixture.
Phosphopeptides were enriched using a PolyMAC-Ti kit (Tymora Analytical, West
Lafayette, IN) 15 . Briefly, the digested peptides were resuspended in 200 µL of Loading buffer, and the sample was vortexed. Next, 50 µL of the PolyMAC/Magnetic
Capture beads were added to the sample and incubated for 20 min. The solvent was for 5 minutes, and the solvent was removed as before. Finally, the beads were incubated twice with 100 µL of Elution buffer for 5 minutes each. The eluents were combined and completely dried in a SpeedVac. formic acid in 80% acetonitrile. The following gradient was used in the LC-MS/MS experiment: the gradient changed from 6% to 30% buffer B within 60 min, then from 30% to 50% buffer B within 10 min; it was increased to 95% buffer B within 5 min, followed by washing the column for 5 min. At the end, the gradient was reduced back to 6% buffer B and the column was equilibrated for 5 min. The flow rate of the UPLC was 250 nL/min. The electrospray ionization emitter tip was generated on the pre-packed column with a laser puller (Model P-2000, Sutter Instrument Co.).
LC-MS/MS
The Easy-nLC-1000 UPLC system was coupled online with a high resolution hybrid linear ion trap orbitrap mass spectrometer (LTQ-Orbitrap Velos Pro, Thermo Fisher). The mass spectrometer was operated in the data-dependent mode in which a full-scan MS was followed by 10 MS/MS scans of the most abundant ions.
High-resolution MS scans were acquired in the Orbitrap (30,000 FWHM at m/z 400)
to monitor peptide ions in the mass range of 350-1500 m/z, followed by collision-induced dissociation MS/MS scans in the ion trap (isolation width 3 m/z, normalized collision energy 30%) of the ten most intense precursor ions. Ions with unassigned charge state as well as singly charged species were excluded. The maximum ion injection times of the survey scans and the MS/MS scans were 250 ms and 25 ms, respectively and the ion target values were set to 1E 6 and 5E 3 , respectively.
Dynamic exclusion duration was set to 60 s. Data were acquired using Xcalibur software. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 8 MS Data Analysis and Label-free Quantification. The raw files were analyzed using MaxQuant software (version 1.5.5.1) with the Andromeda search engine. The main search peptide mass tolerance for precursor ions was set to 10 ppm and ITMS MS/MS mass tolerance was set to 0.6 Da. Enzyme specificity was set to trypsin, and a maximum of two missed cleavages were allowed. Carbamidomethyl cysteine was set as a fixed modification. Methionine oxidation, protein N-terminal acetylation, and phosphorylation on serine, threonine or tyrosine residues were chosen as variable modifications. The spectra were searched against the Uniprot database (Arabidopsis Thaliana, version 2015_01) with common contaminants and concatenated with the reversed versions of all sequences. Protein identification required at least one unique or razor peptide per protein group. The XIC peak intensity was extracted with a match time window of 1.0 min for "match between runs". The required false discovery rate was set to 1% at the peptide and the protein level, and the minimum required peptide length was set to 6 amino acids. Contaminants, reverse identification and proteins only identified by site were excluded from further data analysis using Perseus software (version 1.5.5.0). The peak intensities were log 2 transformed and normalized by subtracting the medians. Missing values were imputed by random sampling from a generated narrow normal distribution around the detection limit before statistical analyses were performed. We also filtered phosphorylation sites unable to be localized were submitted to Motif-X to determine the enriched phosphorylation motifs with the Arabidopsis Uniprot database as background. The significance was set at 0.000001, the width was set at 13, and the minimum number of occurrences was set at 20.
All mass spectrometry proteomics data were deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD010208. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   9 The new phosphoprotein-specific RPPA platform, Reverse Phase PhosphoProtein Array (RP3A), is illustrated in Figure 1 for specific phosphoproteome capture. We The novel RP3A platform has the following unique features: First, it utilizes the features of Ti(IV) chelation which has high specificity towards phosphoproteins and has widely been used in phosphoprotein and peptide enrichment and capture, [16] [17] [18] and the chelating step between Ti(IV) and phosphate groups on phosphoproteins occurs immediately during sample printing, and can tolerate denaturing conditions and salts in the sample. Second, due to its high density in terminal groups, dendrimer can be easily chemically modified and functionalized with abundant Ti(IV) ions for highly efficient phosphoprotein capture. Third, globular and water-soluble dendrimer makes the RP3A surface high accessible by phosphoproteins multi-dimensionally. 19 Overall, the RP3A platform overcomes the limitation of RPPA in detecting proteins with phosphorylation modifications, not only by eliminating the requirement of phospho-specific antibodies but also by significantly reducing the complexity of the crude sample to facilitate the detection of low-abundance phosphoproteins. We first systematically evaluated the specificity, sensitivity, and quantitative capabilities of this new RP3A platform using a transcription factor component, cJun, and its phosphorylated counterpart. The purified recombinant GST-cJun, in either phosphorylated or nonphosphorylated form, in different concentrations ranging from 0 to 250 pg/µL was spiked into B cell lymphoma cell lysate at 1:200 ratio and spotted on the RP3A and regular RPPA membranes, and the GST-cJun signal was detected using anti-GST primary and fluorophore-linked secondary antibodies. As shown in Studying phosphorylation changes and signaling regulation in Arabidopsis allows us to understand molecular mechanisms underlying the responses to environment stresses in plants. 20, 21 However, compared with other organisms such as human and mouse, there are relatively few commercial antibodies specifically against phosphorylated proteins in Arabidopsis, making the validation of phosphoproteins from plants extremely difficult. In this study, we first applied quantitative phosphoproteomics to profile phosphoproteome changes in Arabidopsis with different treatment conditions, and then used RP3A to validate some of the important phosphoproteins. Arabidopsis were treated with 30 minutes of cold stress (4 ºC) and room temperature as the control. Proteins were extracted and digested, and phosphopeptides were enriched and followed by single-run mass spectrometric analysis for each sample. We performed three biological replicates for each plant sample. Among over ten thousand phosphorylation sites we identified in this study, 6,029 were unique class I phosphorylation sites (localization probability > 0.75).
RESULTS AND DISCUSSION
Among them, a total of 1,657 phosphorylation sites representing 1,075
phosphoproteins were significantly up-regulated in cold-treated samples (FDR < 0.05, S0 = 0.2) ( Figure 3A) . Principle Component Analysis (PCA) clearly distinguished overall phosphorylation and signaling after the cold treatment from the basal phosphorylation level in three samples at the room temperature ( Figure 3B ).
Motif analysis shows three main phosphorylation motifs [-pS-P-], [-pS-D-X-E-], and
[-R-X-X-pS-], and [-pS-P-] was in particular enriched upon cold stress, which 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   13 phosphorylates and activates downstream proteins, 24, 25 while biotic stress treatment flg-22 induces phosphorylation of MAP kinases. 26 Some of the phosphorylation changes are known, while the rest are unknown due to the lack of appropriate validation methods. In this experiment, sub-µL amounts of protein samples were spotted onto the RP3A membranes, and the signals were detected using the primary antibodies and fluorophore-functionalized anti-rabbit or anti-mouse secondary antibodies. For the detection of phosphorylation changes of MPK3, MPK4, and MPK6, we used the available antibodies against three individual proteins; for ICE1, SnRK2.6, PYL5, since there is no protein or phosphoprotein antibody available, we used the transgenic plants expressing individual GFP-tagged proteins, GFP-ICE1, GFP-SnRK2.6, or GFP-PYL5. Thus, phosphorylation changes of these proteins can be measured using a high quality anti-GFP antibody on the RP3A platform. As a comparison, the identical spotting, incubation and detection procedure was carried out with the unmodified nitrocellulose membrane as regular RPPA analyses.
One example of detection of protein SnRK2.6 by RP3A and regular RPPA is shown in Figure 4A . We can clearly observe increased phosphorylation in SnRK2.6
after treatment with ABA, while the expression of SnRK2.6 apparently remained constant with or without ABA treatment ( Figure 4B) . To compare the actual phosphorylation changes, the intensity obtained on RP3A were normalized with the regular RPPA to obtain the fold change of the phosphorylation on each protein. The comparative results are shown in Figure 4C , which illustrated the phosphorylation changes in 6 proteins under 4 treatments with three replicates. Overall, phosphorylation changes measured by the RP3A approach fit known literatures very well. The phosphorylation changes measured by the RP3A approach showed that the phosphorylation levels of MPK3, MPK4, and MPK6 were increased after cold and flg22 treatment, which is consistent with previous studies showing that both cold and flg22 can activate MPK cascades. 24, 25 On the other hand, the MPK3, MPK4, and MPK6 could not be activated by ABA treatment, 27 which was confirmed by our RP3A
analyses indicating that the phosphorylation levels of these three MAP kinases were not or only mildly induced after the ABA treatment. The ABA-and mannitol-induced 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 14 phosphorylation of SnRK2.6 detected by RP3A was in agreement with our previous study. 28 These results suggest that RP3A is a reliable method to measure the phosphoryaltion changes. Using this technology, we also examined some phosphorylation events that have not been studied yet. For example, we found that mannitol treatment induced the phosphoryaltion of MPK3 and MPK4, but not MPK6, which suggests that MPK3 and MPK4 are probably involved in the response to ostmotic stress induced by mannitol treatment. Our RP3A data also showed that ABA treatment induced the phosphorylation of PYL5. This new discovery indicated that the phosphorylation may promote the protein stability of PYL5 under stress conditions, and shows clues for investigating the significance of PYL5 phosphorylation in plant signaling in response to environmental stress in our future study. The data also highlighted the unique feature of this new analytical method which allowed us to detect the phosphorylation of PYL5, SnRK2.6 as well as ICE1 even if there is no available antibody specific for the phosphorylation forms of these proteins.
Traditional immunoblotting assay is difficult to validate their phosphorylation change.
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